Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 45

  • Unknown sort schema '{last_sort_schema}' ignored
1.

Study of Two Dose Regimens of Ticagrelor Compared with Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease (STEEL-PCI).

Orme RC, Parker WAE, Thomas MR, Judge HM, Baster K, Sumaya W, Morgan KP, McMellon HC, Richardson JD, Grech ED, Wheeldon NM, Hall IR, Iqbal J, Barmby D, Gunn JP, Storey RF.

Circulation. 2018 Jun 21. pii: CIRCULATIONAHA.118.034790. doi: 10.1161/CIRCULATIONAHA.118.034790. [Epub ahead of print]

PMID:
29930021
2.
3.

Risk factors for bleeding during anticoagulation of atrial fibrillation in older and younger patients in clinical practice.

Abdelhafiz AH, Wheeldon NM.

Am J Geriatr Pharmacother. 2008 Mar;6(1):1-11. doi: 10.1016/j.amjopharm.2008.03.005.

PMID:
18396243
4.

Hemodynamic assessment of mitral mechanical prostheses under high flow conditions: comparison between dynamic exercise and dobutamine stress.

Hobson NA, Wilkinson GA, Cooper GJ, Wheeldon NM, Lynch J.

J Heart Valve Dis. 2006 Jan;15(1):87-91.

PMID:
16480017
5.

Anticoagulation of atrial fibrillation in older people: a clinical practice observational study.

Abdelhafiz AH, Wheeldon NM.

J Am Geriatr Soc. 2006 Jan;54(1):176-7. No abstract available.

PMID:
16420226
6.

Hemodynamic performance of the Ultracor and Carpentier-Edwards aortic prostheses using exercise and dobutamine stress echocardiography.

Hobson NA, Wilkinson GA, Wheeldon NM, Lynch J.

J Heart Valve Dis. 2005 Nov;14(6):828-34.

PMID:
16359066
7.
9.

Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect.

Viberti G, Wheeldon NM; MicroAlbuminuria Reduction With VALsartan (MARVAL) Study Investigators.

Circulation. 2002 Aug 6;106(6):672-8.

10.

Coronary angiography using 4 French catheters.

Wheeldon NM.

Int J Cardiol. 2001 Aug;80(1):5-6. No abstract available.

PMID:
11532540
11.

Screening for atrial fibrillation in primary care.

Wheeldon NM, Tayler DI, Anagnostou E, Cook D, Wales C, Oakley GD.

Heart. 1998 Jan;79(1):50-5.

12.

Chronic atrial fibrillation: optimizing anticoagulation.

Wheeldon NM.

QJM. 1997 Oct;90(10):609-11. No abstract available.

PMID:
9415341
13.

Haemodynamic and endocrine effects of type 1 angiotensin II receptor blockade in patients with hypoxaemic cor pulmonale.

Kiely DG, Cargill RI, Wheeldon NM, Coutie WJ, Lipworth BJ.

Cardiovasc Res. 1997 Jan;33(1):201-8.

PMID:
9059545
14.

Antithrombotic therapy for non-rheumatic atrial fibrillation.

Wheeldon NM.

QJM. 1996 Oct;89(10):800-1; author reply 801-2. No abstract available.

PMID:
8944237
15.

Effects of brain natriuretic peptide on exercise hemodynamics and neurohormones in isolated diastolic heart failure.

Clarkson PB, Wheeldon NM, MacFadyen RJ, Pringle SD, MacDonald TM.

Circulation. 1996 Jun 1;93(11):2037-42.

16.

Left atrial size and function: assessment using echocardiographic automatic boundary detection.

Clarkson PB, Wheeldon NM, Lim PO, Pringle SD, MacDonald TM.

Br Heart J. 1995 Dec;74(6):664-70.

17.

Acute effects of atrial natriuretic peptide on left ventricular diastolic function. a pulsed wave Doppler study in man.

Clarkson PB, Wheeldon NM, Macleod C, Coutie W, MacDonald TM.

Eur Heart J. 1995 Nov;16(11):1710-15.

PMID:
8881869
18.

A double-blind comparison of bisoprolol and atenolol in patients with essential hypertension.

Wheeldon NM, MacDonald TM, Prasad N, Maclean D, Peebles L, McDevitt DG.

QJM. 1995 Aug;88(8):565-70.

PMID:
7648243
19.

Open access echocardiography. Single assessment may be dangerous.

MacFadyen RJ, MacDonald TM, Clarkson P, Wheeldon NM.

BMJ. 1995 Jul 29;311(7000):327; author reply 327-8. No abstract available.

20.

Atrial fibrillation and anticoagulant therapy.

Wheeldon NM.

Eur Heart J. 1995 Mar;16(3):302-12. Review. No abstract available.

PMID:
7789371

Supplemental Content

Loading ...
Support Center